Citadel Advisors
ERAS icon

Citadel Advisors’s Erasca ERAS Stock Holding History

Citadel Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.06M Sell
498,381
-531,964
-52% -$6.29M ﹤0.01% 3569
2025
Q4 		$3.83M Buy
1,030,345
+688,546
+201% +$1.94M ﹤0.01% 4742
2025
Q3 		$745K Buy
+341,799
New +$544K ﹤0.01% 8195
2025
Q2 		– Sell
-402
Closed -$538 – 13197
2025
Q1 		$551 Sell
402
-4,287,967
-100% -$7.36M ﹤0.01% 14246
2024
Q4 		$10.8M Sell
4,288,369
-27,304
-0.6% -$74.9K ﹤0.01% 2899
2024
Q3 		$11.8M Buy
4,315,673
+1,022,302
+31% +$2.88M ﹤0.01% 2675
2024
Q2 		$7.77M Buy
3,293,371
+2,456,057
+293% +$5.3M ﹤0.01% 3115
2024
Q1 		$1.72M Sell
837,314
-1,310,280
-61% -$2.62M ﹤0.01% 5817
2023
Q4 		$4.57M Buy
2,147,594
+384,949
+22% +$812K ﹤0.01% 3924
2023
Q3 		$3.47M Buy
1,762,645
+465,813
+36% +$1.19M ﹤0.01% 4234
2023
Q2 		$3.58M Sell
1,296,832
-2,033,736
-61% -$5.79M ﹤0.01% 4166
2023
Q1 		$10M Buy
3,330,568
+2,471,895
+288% +$8.99M ﹤0.01% 2813
2022
Q4 		$3.7M Buy
858,673
+744,039
+649% +$5.04M ﹤0.01% 4390
2022
Q3 		$894K Buy
114,634
+23,524
+26% +$189K ﹤0.01% 7233
2022
Q2 		$507K Buy
91,110
+44,648
+96% +$292K ﹤0.01% 8610
2022
Q1 		$400K Buy
+46,462
New +$538K ﹤0.01% 9897
2021
Q4 		– Sell
-10,968
Closed -$233K – 14026
2021
Q3 		$233K Buy
+10,968
New +$226K ﹤0.01% 11634

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Citadel Advisors's ERAS Position: Q1 2026 in Review

Citadel Advisors reduced its Erasca (ERAS) stake by 52% in Q1 2026, selling an estimated $6.29M and leaving 498,381 shares worth $8.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Citadel Advisors first reported a position in ERAS in Q3 2021 and has held it in 17 quarters since. The position peaked at $11.8M in Q3 2024. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Citadel Advisors held 498,381 shares of Erasca worth $8.06M as of Q1 2026.
  • Citadel Advisors sold 531,964 Erasca shares in Q1 2026, an estimated $6.29M.
  • Erasca made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3569 holding.
  • Citadel Advisors first reported a position in Erasca in Q3 2021 and has held it in 17 quarters since.
  • Citadel Advisors's Erasca position peaked at $11.8M in Q3 2024.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.